Family Medicine · Las Vegas, NV
NPI
1245492966
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
546 N Eastern Ave Ste 140
Las Vegas, NV, 89101
Phone (702) 234-1691
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
846 services
Medicare patients, 2024
181
Average age 71
Drug cost, 2024
$1.4M
20,351 prescriptions
Company payments, 2025
$108K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rogelio Machuca was code 99213 (office e&m - established), 480 times for 157 patients. In total Rogelio Machuca billed 846 services in 17 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 480 | 157 | $64.28 | $31K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 109 | 14 | $0.34 | $36.68 |
| 99214 Office E&M - Established | Office | 92 | 72 | $91.45 | $8,413 |
| 99212 Office E&M - Established | Office | 65 | 43 | $31.38 | $2,040 |
| 96372 Injection Administration | Office | 39 | 16 | $9.30 | $363 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 21 | 13 | $0.93 | $19.53 |
| 99203 Office E&M - New | Office | 14 | 14 | $62.99 | $882 |
By year: 2022 $91K for 4,602 services; 2023 $39K for 2,712 services; 2024 $44K for 846 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 21 | 19 | $3.44 | $72.18 |
| 87428 Infectious Agent Detection by DNA/RNA | 18 | 17 | $30.72 | $553 |
| 87426 Immunoassay | 13 | 11 | $34.14 | $444 |
Medicare prescription drug claims, 2024
In 2024, the drug Rogelio Machuca prescribed most often to Medicare patients was Atorvastatin Calcium, with 910 prescriptions and refills. In total Rogelio Machuca wrote 20,351 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 910 | 1,929 | 281 | $6,734 |
| Gabapentin Generic | 521 | 773 | 145 | $9,883 |
| Metformin Hcl Generic | 508 | 1,161 | 155 | $2,592 |
| Lisinopril Generic | 503 | 1,115 | 164 | $2,913 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 495 | 549 | 130 | $21K |
| Levothyroxine Sodium Generic | 489 | 950 | 135 | $4,653 |
| Omeprazole Generic | 471 | 959 | 150 | $3,527 |
| Amlodipine Besylate Generic | 422 | 950 | 136 | $1,604 |
| Azithromycin Generic | 398 | 399 | 241 | $1,482 |
| Glimepiride Generic | 326 | 771 | 94 | $1,969 |
| Furosemide Generic | 316 | 537 | 100 | $1,028 |
| Ibuprofen Generic | 298 | 368 | 92 | $2,550 |
| Losartan Potassium Generic | 291 | 656 | 89 | $2,338 |
| Famotidine Generic | 283 | 522 | 95 | $2,209 |
| Mirtazapine Generic | 282 | 460 | 82 | $4,037 |
Brand drugs: 2,502 claims; generic drugs: 17,612 claims; opioid claims: 453.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rogelio Machuca $108K ($13K in general payments such as food, travel and fees and $95K for research) from 19 companies. The largest payer was Genentech, Inc. with $81K.
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. ROG.SW | 4 | $81K |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 1 | $14K |
| Hoffmann-La Roche Limited ROG.SW | 4 | $12K |
| Genzyme Corporation SNY | 3 | $848 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $195 |
| Abbott Laboratories ABT | 4 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $82.21 |
| Mannkind Corporation MNKD | 2 | $61.36 |
| Lilly USA, LLC LLY | 3 | $50.49 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $49.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.